No abstract available
MeSH terms
-
Aged, 80 and over
-
Angiogenesis Inhibitors / administration & dosage
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Cerebral Angiography
-
Female
-
Humans
-
Optic Neuropathy, Ischemic / complications
-
Optic Neuropathy, Ischemic / drug therapy*
-
Optic Neuropathy, Ischemic / physiopathology
-
Papilledema / drug therapy*
-
Papilledema / etiology
-
Papilledema / physiopathology
-
Retina / pathology
-
Retina / physiopathology
-
Retinal Artery / drug effects
-
Retinal Artery / pathology
-
Retinal Artery / physiopathology
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / metabolism
-
Vision, Low / drug therapy
-
Vision, Low / etiology
-
Vision, Low / physiopathology
-
Visual Fields / drug effects
-
Vitreous Body / drug effects
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Bevacizumab